Skip to content

Opko Health OPK Diagnostics — Gross Profit

Other segment segments

Pharmaceutical
$29.71M+22.3%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOClinical Diagnostics — Gross Profit
$181.8M+2.4%
Labcorp Holdings logo
LHDiagnostics — Operating Income
$458.7M+7.3%
Danaher logo
DHRDiagnostics — Operating Income (Loss)
$674M-6.1%
Agilent Technologies logo
AGross Profit
$990M+14.3%
Revvity logo
RVTYDiagnostics — Segment operating income
$76.12M+2.8%
Danaher logo
DHRGross Profit
$3.59B+2.3%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's diagnostics — gross profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's diagnostics — gross profit?
Opko Health (OPK) reported diagnostics — gross profit of $16.04M in Q1 2026.
How has Opko Health's diagnostics — gross profit changed year-over-year?
Opko Health's diagnostics — gross profit decreased by 12.5% year-over-year, from $18.33M to $16.04M.
What is the long-term trend for Opko Health's diagnostics — gross profit?
Over 3 years (2022 to 2025), Opko Health's diagnostics — gross profit has grown at a -21.1% compound annual growth rate (CAGR), from $128.08M to $62.92M.
What does diagnostics — gross profit mean?
Calculated as the revenue generated from diagnostic services minus the direct costs of providing those services. This metric measures the fundamental profitability of the diagnostics segment before accounting for operating expenses. It is a key indicator of pricing power and cost control within the laboratory and testing operations.